Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma

The aims of this study were to evaluate the frequency of dose-limiting toxicities and to find the recommended dose of combination chemotherapy with sorafenib and transcatheter arterial infusion (TAI) using cisplatin for patients with advanced hepatocellular carcinoma (HCC), for whom surgical resecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagihara, Atsushi, Ikeda, Masafumi, Ueno, Hideki, Morizane, Chigusa, Kondo, Shunsuke, Nakachi, Kohei, Mitsunaga, Shuichi, Shimizu, Satoshi, Kojima, Yasushi, Suzuki, Eiichiro, Katayama, Kazuhiro, Imanaka, Kazuho, Tamai, Chie, Inaba, Yoshitaka, Sato, Yozo, Kato, Mina, Okusaka, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317950/
https://www.ncbi.nlm.nih.gov/pubmed/24438504
http://dx.doi.org/10.1111/cas.12353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317950/
https://www.ncbi.nlm.nih.gov/pubmed/24438504
http://dx.doi.org/10.1111/cas.12353

Ejemplares similares